Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions.
暂无分享,去创建一个
[1] N. Hellmann,et al. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development. , 2015, Journal of pharmaceutical sciences.
[2] J. Tack,et al. Intestinal behavior of the ester prodrug tenofovir DF in humans. , 2015, International journal of pharmaceutics.
[3] Clive G. Wilson,et al. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] J. Dressman,et al. Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data. , 2014, Journal of pharmaceutical sciences.
[5] M. Corsetti,et al. Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] Christel A. S. Bergström,et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] P. Annaert,et al. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] A. Mohammed,et al. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. , 2013, International journal of pharmaceutics.
[10] A. Müllertz,et al. Bile salts and their importance for drug absorption. , 2013, International journal of pharmaceutics.
[11] C. Porter,et al. Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles , 2013, Pharmaceutical Research.
[12] Carson C. Chow,et al. A new method for determining gastric acid output using a wireless pH‐sensing capsule , 2013, Alimentary pharmacology & therapeutics.
[13] T. Koch,et al. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs. , 2013, Biochemical pharmacology.
[14] C. Reppas,et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. , 2012, Molecular pharmaceutics.
[15] K. Goumas,et al. Precipitation in and Supersaturation of Contents of the Upper Small Intestine After Administration of Two Weak Bases to Fasted Adults , 2011, Pharmaceutical Research.
[16] F. Lammert,et al. Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid. , 2011, International journal of pharmaceutics.
[17] A. Müllertz,et al. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies , 2010, The Journal of pharmacy and pharmacology.
[18] Kayoko Ohura,et al. The role of intestinal carboxylesterase in the oral absorption of prodrugs. , 2010, Current drug metabolism.
[19] G. Duchateau,et al. Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs , 2009, Pharmaceutical Research.
[20] P Augustijns,et al. Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. , 2009, Journal of pharmaceutical sciences.
[21] J. Tack,et al. Parallel Monitoring of Plasma and Intraluminal Drug Concentrations in Man After Oral Administration of Fosamprenavir in the Fasted and Fed State , 2007, Pharmaceutical Research.
[22] M. Armand. Lipases and lipolysis in the human digestive tract: where do we stand? , 2007, Current opinion in clinical nutrition and metabolic care.
[23] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[24] J. Dressman,et al. Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies , 2006, Pharmaceutical Research.
[25] P. Hellström,et al. The physiology of gastric emptying. , 2006, Best practice & research. Clinical anaesthesiology.
[26] Patrick Augustijns,et al. Characterization of fasted‐state human intestinal fluids collected from duodenum and jejunum , 2006, The Journal of pharmacy and pharmacology.
[27] H. Lennernäs,et al. A Clinical Single-Pass Perfusion Investigation of the Dynamic in Vivo Secretory Response to a Dietary Meal in Human Proximal Small Intestine , 2006, Pharmaceutical Research.
[28] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[29] J. Keller,et al. Human pancreatic exocrine response to nutrients in health and disease , 2005, Gut.
[30] R. Lehner,et al. Techniques to measure lipase and esterase activity in vitro. , 2005, Methods.
[31] H. Kristensen,et al. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[32] A. Nagao,et al. Phospholipids affect the intestinal absorption of carotenoids in mice , 2003, Lipids.
[33] C. Luscombe,et al. Bile Salt/Lecithin Mixed Micelles Optimized for the Solubilization of a Poorly Soluble Steroid Molecule Using Statistical Experimental Design , 2003, Drug development and industrial pharmacy.
[34] M. Kushiro,et al. Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. , 2001, The Journal of nutrition.
[35] S. Noh,et al. Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats. , 2001, The Journal of nutrition.
[36] D. M. Amundson,et al. Fluorometric method for the enzymatic determination of cholesterol. , 1999, Journal of biochemical and biophysical methods.
[37] A. Mäkelä,et al. Duodenal secretion of phospholipase A2, amylase, and bicarbonate in chronic pancreatitis , 1998, Journal of Gastroenterology.
[38] J. Dressman,et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.
[39] J. Calbet,et al. Role of caloric content on gastric emptying in humans. , 1997, The Journal of physiology.
[40] D. Lairon,et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. , 1996, The American journal of physiology.
[41] P. Sauve,et al. Intestinal cholesterol uptake: Comparison between mixed micelles containing lecithin or lysolecithin , 1985, Lipids.
[42] A. Hofmann,et al. Enzymatic measurement of choline-containing phospholipids in bile. , 1981, Journal of lipid research.
[43] G. Duchateau,et al. Plant sterol analysis in relation to functional foods. , 2004 .